International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood
Endocrine Reviews · 08.05.2023 · 44 (3) · 539-565
DOI: 10.1210/endrev/bnad002 ↗Kurz gefasst
Leitlinie in der Zeitschrift Endocrine Reviews, online erschienen am 13.01.2023. Verfasst von Anita C S Hokken-Koelega und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Body Height, Human Growth Hormone. Die Arbeit wurde bisher 202-mal zitiert (Crossref) und nennt 247 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This International Consensus Guideline was developed by experts in the field of small for gestational age (SGA) of 10 pediatric endocrine societies worldwide. A consensus meeting was held and 1300 articles formed the basis for discussions. All experts voted about the strengths of the recommendations. The guideline gives new and clinically relevant insights into the etiology of short stature after SGA birth, including novel knowledge about (epi)genetic causes. Further, it presents long-term consequences of SGA birth and also reviews new treatment options, including treatment with gonadotropin-releasing hormone agonist (GnRHa) in addition to growth hormone (GH) treatment, as well as the metabolic and cardiovascular health of young adults born SGA after cessation of childhood GH treatment in comparison with appropriate control groups. To diagnose SGA, accurate anthropometry and use of national growth charts are recommended. Follow-up in early life is warranted and neurodevelopment evaluation in those at risk. Excessive postnatal weight gain should be avoided, as this is associated with an unfavorable cardiometabolic health profile in adulthood. Children born SGA with persistent short stature < −2.5 SDS at age 2 years or < −2 SDS at 3 to 4 years of age, should be referred for diagnostic workup. In case of dysmorphic features, major malformations, microcephaly, developmental delay, intellectual disability, and/or signs of skeletal dysplasia, genetic testing should be considered. Treatment with 0.033 to 0.067 mg GH/kg/day is recommended in case of persistent short stature at age of 3 to 4 years. Adding GnRHa treatment could be considered when short adult height is expected at pubertal onset. All young adults born SGA require counseling to adopt a healthy lifestyle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center, 3015 CN Rotterdam, The Netherlands.
- Department of Pediatrics, Federal University of Parana, 1154 Curitiba, Brazil.
- Department of Systems Medicine, University of Rome 'Tor Vergata', 00133 Rome, Italy.
- Diabetology and Growth Disorders Unit, IRCCS "Bambino Gesù" Children's Hospital, 00146 Rome, Italy.
- Department of Women's and Children's Health, Karolinska Institute, 17177 Stockholm, Sweden.
- Department of Pediatrics, The Sahlgrenska Academy, the University of Gothenburg and Queen Silvia Children's Hospital, 41650 Gothenburg, Sweden.
ORCID-Profile: Anita C S Hokken-Koelega, Jovanna Dahlgren, Reiko Horikawa, Veronica Mericq, Robert Rapaport, Andrew Dauber, Christina Kanaka-Gantenbein
Zitieren
APA
Hokken-Koelega, A. C. S., van der Steen, M., Boguszewski, M. C. S., Cianfarani, S., Dahlgren, J., Horikawa, R., Mericq, V., Rapaport, R., Alherbish, A., Braslavsky, D., Charmandari, E., Chernausek, S. D., Cutfield, W. S., Dauber, A., Deeb, A., Goedegebuure, W. J., Hofman, P. L., Isganatis, E., Jorge, A. A., …, & Yau, M. (2023). International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood. Endocrine Reviews, 44(3), 539-565. https://doi.org/10.1210/endrev/bnad002
Vancouver
Hokken-Koelega ACS, van der Steen M, Boguszewski MCS, Cianfarani S, Dahlgren J, Horikawa R, et al. International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood. Endocrine Reviews. 2023;44(3):539-565. doi:10.1210/endrev/bnad002
BibTeX
@article{HokkenKoelega2023,
author = {Hokken-Koelega, Anita C S and van der Steen, Manouk and Boguszewski, Margaret C S and Cianfarani, Stefano and Dahlgren, Jovanna and Horikawa, Reiko and Mericq, Veronica and Rapaport, Robert and Alherbish, Abdullah and Braslavsky, Debora and Charmandari, Evangelia and Chernausek, Steven D and Cutfield, Wayne S and Dauber, Andrew and Deeb, Asma and Goedegebuure, Wesley J and Hofman, Paul L and Isganatis, Elvira and Jorge, Alexander A and Kanaka-Gantenbein, Christina and Kashimada, Kenichi and Khadilkar, Vaman and Luo, Xiao-Ping and Mathai, Sarah and Nakano, Yuya and Yau, Mabel},
title = {International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood},
journal = {Endocrine Reviews},
year = {2023},
volume = {44},
number = {3},
pages = {539--565},
doi = {10.1210/endrev/bnad002}
}
EUVIMED